Larimar Therapeutics, Inc. - Common Stock (NQ:LRMR)

2.440 +0.320 (+15.09%)

Delayed Quote Updated: 4:00 PM EDT, Oct 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Larimar Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday ↗

July 05, 2022

Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.

Via Benzinga

Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session ↗

July 01, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.

Via Benzinga

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Investor Alert: Investigation over Potential Wrongdoing ↗

May 02, 2022

San Diego, CA -- (SBWIRE) -- 05/02/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Larimar Therapeutics, Inc.

Via SBWire

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Investor Notice: Investigation over Possible Violations of Securities Laws ↗

March 02, 2022

San Diego, CA -- (SBWIRE) -- 03/02/2022 -- Larimar Therapeutics, Inc is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 18, 2022

Gainers Biofrontera (NASDAQ:BFRA) stock moved upwards by 11.8% to $3.49 during Friday's pre-market session. The market value of their outstanding shares is at $98.9...

Via Benzinga

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Larimar Therapeutics, Inc. (LRMR) Investigation

February 17, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 17, 2022

Gainers NeuroOne Medical Tech (NASDAQ:NMTC) shares moved upwards by 12.3% to $3.0 during Thursday's pre-market session. The company's market cap stands at $48.5...

Via Benzinga

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Larimar Therapeutics, Inc. (LRMR) Investigation

February 16, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

55 Biggest Movers From Yesterday ↗

February 16, 2022

Check this out: Insiders Buy Around $112M Of 3 Stocks. Losers Larimar Therapeutics, Inc. (NASDAQ: LRMR) shares fell 52.1% to close at $4.01 on Tuesday after the company...

Via Benzinga

Mid-Afternoon Market Update: Dow Jumps 400 Points; Marriott International Tops Q4 Views ↗

February 15, 2022

US stocks remained higher toward the end of trading session on Tuesday after Russia announced it would pull back some troops positioned on the Ukrainian border.

Via Benzinga

Mid-Day Market Update: Crude Oil Down 4%; US Producer Prices Rise 1% In January ↗

February 15, 2022

US stocks remained higher midway through trading on Tuesday after Russia announced it would pull back some troops positioned on the Ukrainian border.

Via Benzinga

31 Stocks Moving In Tuesday's Mid-Day Session ↗

February 15, 2022

Gainers Resonant Inc. (NASDAQ: RESN) jumped 249% to $4.29 after Murata Electronics announced plans to buy the company at $4.50 per share in cash. Tower Semiconductor Ltd. (NASDAQ...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

February 15, 2022

Tuesday's session saw 95 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher On Easing Russia-Ukraine Tensions ↗

February 15, 2022

US stocks opened on a strong note this morning after Russia announced it would pull back some troops positioned on the Ukrainian border.

Via Benzinga

Futures Soar, Safe Havens Tumble After Russia Announces Some Troops Returning To Base ↗

February 15, 2022

With less than 24 hours to go until the Feb 16 CNN and CIA-leaked Putin

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2022 ↗

February 15, 2022

Upgrades For Blue Bird Corp (NASDAQ:BLBD), Roth Capital upgraded the previous rating of Neutral to Buy. Blue Bird earned $0.07 in the first quarter, compared to $0.00 in the year-...

Via Benzinga

The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics ↗

February 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus ImmunityBio Says Cancer Combo Therapy Produces Positive Results In Late-Stage...

Via Benzinga

Larimar Stock Plunges As FDA Asks For Additional Data To Resolve Clinical Hold On Friedreich's Ataxia Program ↗

February 15, 2022

Larimar Therapeutics Inc (NASDAQ: LRMR) has received feedback from the FDA regarding the clinical hold on its CTI-1601 program. The FDA stated it is...

Via Benzinga

22 Stocks Moving in Tuesday's Pre-Market Session ↗

February 15, 2022

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check this out: Discover Financial Services And 3 Other...

Via Benzinga

41 Biggest Movers From Yesterday ↗

January 27, 2022

Gainers Ebang International Holdings Inc. (NASDAQ: EBON) shares gained 35.4% to settle at $1.09 on Wednesday as investors weighed the Federal Reserve Reserve decision to leave...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Down 1%; Protagonist Therapeutics Shares Plummet ↗

September 17, 2021

Toward the end of trading Friday, the Dow traded down 0.47% to 4,587.22 while the NASDAQ fell 1.05% to 15,023.11. The S&P also fell, dropping 0.85% to 4,435.65. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 15, 2021

Gainers Larimar Therapeutics (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 06, 2021

Gainers Advaxis (NASDAQ:ADXS) shares increased by 43.13% to $0.68 during Tuesday's regular session. The current volume of 106.3 million shares is 1084.49% of Advaxis...

Via Benzinga

42 Stocks Moving In Tuesday's Mid-Day Session ↗

July 06, 2021

Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 74% to $9.47. BSQUARE Corporation (NASDAQ: BSQR) shares jumped 48.2% to $5.90 after dropping around 10% on Friday. Bridgeline...

Via Benzinga

77 Biggest Movers From Yesterday ↗

August 13, 2021

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to...

Via Benzinga

Notable Insider Buys In The Past Week: Asana, Transocean, IPOS, SPACS And More ↗

July 05, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. A couple of special purpose acquisition companies and some...

Via Benzinga

61 Biggest Movers From Yesterday ↗

July 07, 2021

Gainers BSQUARE Corporation (NASDAQ: BSQR) shares climbed 77.1% to close at $7.05 on Tuesday on abnormally-high volume. The company’s stock dropped around 10% on Friday....

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 02, 2021

Gainers Odonate Therapeutics (NASDAQ:ODT)...

Via Benzinga

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes ↗

May 31, 2021

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 28, 2021

Gainers Iterum Therapeutics (NASDAQ:ITRM) shares moved upwards by 21.13% to $1.49 during Friday's pre-market session. The company's market cap stands at $266.9...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.